GB virus C and hepatitis C virus infections in hemodialysis patients in eight japanese centers

Nephron

Volumn 76, Issue 2, 1997, Pages 171-175

  Watanabea, Tetsuya ^a   Ishiguro, Moioyuki ^b   Kametani, Masaaki ^c   Sugai, Yoshiki ^d   Takakuwa, Kaoru ^e   Akahane, Yoshihiro ^f   Masuko, Kazuo ^g   Shimizu, Masaru ^h   Kojima, Mineo ⁱ   Ftijita, Kimio ^j   Tsuda, Fumio ^k   Okamoto, Hiroaki ^l  

^a Jichi Medical University   (Japan)

^b Hirano General Hospital   (Japan)

^c Takayama Red Cross Hospital   (Japan)

^d Iwaki Kyoritsu General Hospital   (Japan)

^e Takakuwa Clinic   (Japan)

^f UNIVERSITY OF YAMANASHI   (Japan)

^g Masuko Hospital and Masuko Institute for Medical Research   (Japan)

^h Gifu Prefectoral Gifu Hospital   (Japan)

ⁱ Department of Medicine   (Japan)

^j HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k Shinagawa ku   (Japan)

^l JICHI MEDICAL UNIVERSITY   (Japan)

more..

Author keywords

Blood transfusion; Hemodialysis; Hepatitis C viruses; Hepatitis viruses

Indexed keywords

VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE DURATION; FEMALE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS VIRUS; HOSPITAL INFECTION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; VIRUS INFECTION;

ALANINE TRANSAMINASE; BLOOD DONORS; BLOOD TRANSFUSION; FEMALE; FLAVIVIRIDAE; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS, VIRAL, HUMAN; HUMANS; INCIDENCE; JAPAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RENAL DIALYSIS; TIME FACTORS;

EID: 0030955960     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190165     Document Type: Article

References (18)

1. Alter HJ., Bradley DW: Non-A, non-B hepatitis unrelated to the hepatitis C virus (non-ABC)., Semin Liver Dis 1995:15:110-120.
2. Simons JN., Leary TP, Dawson GJ., Pilot-Ma-tias TJ, Mucrhot TAS., Schlauder GG., Dcsai SM, Mushahwar IK: Isolation of novel virus-like sequences associated with human hepatitis., Nat Med 1995;1:564-569.
3. Leary TP., Muerhol TAS., Simons JN, Pilot-Matias TJ., Erker JC, Chalmers ML, Schlauder GG., Dawson GJ., Desai SM., Mushahwar IK: Sequence and genomic organization of GBV-C: A novel member of the Flaviviridac associated with human non-A-E hepatitis., J Med Virol 1996:48:60-67.
4. Yoshiba M., Okamoto F., Mishiro S: Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology., Lancet 1995:346:1131-1132.
5. Linnen J., Wages J., Zhang-Keek ZY., Fry KE., Krawczynski KZ., Alter H., Koonin E, Gallagher M., Alter M, Hadziyannis S., Karayiannis P., Fung K., Nakatsuji Y., Shill JWK., Young L., Pia-tak M, Hoover C, Fernandez J., Chen S., Zou JC., Morris T., Hyams KC., Ismay S., Lifson JD., Hess G., Foung SKH., Thomas H., Bradley D., Margolis H., Kim JP: Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent., Science 1996; 271:505-508.
6. London WT, Di FM, Sutnick A., Blumberg BS: An epidemic of hepatitis in a chronic-hemodialysis unit., Australia antigen and differences in host response., N Engl J Med 1969:281:571-578.
7. Szmuness W., Prince AM., Grady GF., Mann MK, Levine RW., Friedman EA., Jacobs MJ., Josephson A., Ribot S., Shapiro FL., Stcnzcl KH., Suki WN., Vyas G: Hepatitis B infection., A point-prevalence study in 15 US hemodialysis centers., JAMA 1974:227:901-906.
8. Snydman DR, Bryan JA, HansonB: Hemodialysis-associated hepatitis in the United Stales-1972., J Infect Dis 1975;132:109-113.
9. Mondelli MU., Cristina G., Piazza V, Cerino A., Villa G., Salvadeo A: High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second-generation assay., Nephron 1992;61:350-351.
10. Knudsen F., Wantzin P., Rasmussen K., Ladc-foged SD., Lokkcgaard N., Rasmussen LS., Lassen A., Krogsgaard K: Hepatitis C in dialysis patients: Relationship to blood transfusions, dialvsis and liver disease., Kidney Int 1993:43: 1353-1356.
11. Shimizu M., Osada K., Okamoto H: Transfusion-transmitted hepatitis G virus following open heart surgery (letter)., Transfusion 1996: 36:937.
12. Okamoto H., Mishiro S., Tokita H., Tsuda F., Miyakawa Y, Mavumi M: Superinfcction of chimpanzees carrying hepatitis C virus of genotype 11/lb with that of genotype III/2a or 1/la., Hepatology 1994;20:1131-1136.
13. Kzuka H., Ohmura K., Ishijima A., Satoh K., Tanaka T., Tsuda F, Okamoto H, Miyakawa Y., Mavumi M: Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg., Vox Sang 1992:63:107-111.
14. Masuko K., Mitsui T, Iwano K., Yamazaki C., Okuda K., Meguro T., Murayama N., lnoue T., Tsuda F., Okamoto H., Miyakawa Y, Mavumi M: Infection with hepatitis GB virus C in patients on maintenance hemodialysis., N Engl J Med 1996:334:1485-1490.
15. Alter HJ: The cloning and clinical implications of HGV and HGBV-C (editorial)., N Engl J Med 1996:334:1536-1537.
16. de Lamballerie S., Charrci RN., Dussol B: Hepatitis GB virus C in patients on hemodialysis (correspondence)., N Engl J Med 1996:334: 1549.
17. Goldblum SE, Reed WP: Host defenses and immunologic alterations associated with chronic hemodialysis., Ann Intern Med 1980; 93:597-613.
18. Dcscamps-Lalscha B, Herbelin A: Long-term dialysis and cellular immunity: A critical survey., Kidney Int 1993:41:S135-S142